The forecast for malignant neoplasms mortality in Canada shows a steady decline from 2024 to 2028, with rates decreasing from 221.7 to 207.3 deaths per 100,000 men. This represents a year-on-year decline of approximately 1.7%. Notably, the compound annual growth rate (CAGR) over the five-year period indicates an average annual reduction of around 1.7% in mortality rates. In 2023, data showed a rate of around 224 deaths per 100,000 men.
Future trends to watch include advancements in cancer treatment and early detection technologies, policy interventions on lifestyle choices such as smoking cessation, and healthcare access improvements, which could further impact mortality rates.
